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https://doi.org/10.1186/s12889-020-08737-yRESEARCH ARTICLE Open AccessCross-cultural validation of the motivation
to change lifestyle and health behaviours
for dementia risk reduction scale in the
Dutch general population
Tessa Joxhorst, Joyce Vrijsen* , Jacobien Niebuur and Nynke SmidtAbstract
Background: This study aimed to translate and validate the Motivation to Change Lifestyle and Health Behaviours
for Dementia Risk Reduction (MCLHB-DRR) scale in the Dutch general population.
Methods: A random sample of Dutch residents aged between 30 and 80 years old were invited to complete an
online questionnaire including the translated MCLHB-DRR scale. Exploratory and confirmatory factor analyses (EFA
and CFA) were conducted to assess construct validity. Cronbach’s alpha was calculated to assess internal
consistency.
Results: Six hundred eighteen participants completed the questionnaire. EFA and Cronbach’s alpha showed that
four items were candidate for deletion. CFA confirmed that deleting these items led to an excellent fit (RMSEA =
0.043, CFI = 0.960, TLI = 0.951, χ2/df = 2.130). Cronbach’s alpha ranged from 0.69 to 0.93, indicating good internal
consistency.
Conclusion: The current study demonstrated that the Dutch MCLHB-DRR scale is a valid scale for assessing health
beliefs and attitudes towards dementia risk reduction among Dutch adults aged between 30 and 80 years old.
Keywords: Dementia, Health behavior, Risk reduction behavior, Lifestyle, Cross-cultural validation, Validation studyBackground
Dementia is a major public health concern for society.
The prevalence of dementia increases rapidly, from 50
million cases worldwide in 2019 to an estimated 152
million cases in 2050 [1]. In the Netherlands dementia
was the leading cause of death in 2018 [2]. The national
expenses for dementia were 9,1 billion euros in 2017,
which accounted for 10.3% of the total Dutch health
care expenses [3]. Also the number of patients with de-
mentia increases rapidly in the Netherlands, which is© The Author(s). 2020, corrected publication 2
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The Netherlandsestimated to rise from 280,000 cases in 2018 to more
than 520,000 cases in 2040 [4]. The increasing number
of dementia patients carries a high socioeconomic bur-
den for society, because of the associated rising health
care costs and the burdensome effects of the disease on
patients, their families and caregivers [5]. The World
Health Organization (WHO) highlights dementia as a
public health priority and advocates for action to de-
crease its social and economic burden [6].
The increase in the number of dementia patients is
mainly attributable to population ageing, since age is the
most important risk factor for dementia [7, 8]. In addition
to non-modifiable risk factors for dementia like age and
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ticular Alzheimer’s disease and vascular dementia [9–12].
Recently, the evidence for these potential modifiable risk
factors for dementia was summarized by Livingston et al.
(2017) [12]. They found that 35% of all dementia cases
worldwide are attributable to nine modifiable risk factors
and recommended to start interventions including more
childhood education, promotion of exercise, reduction of
smoking, maintaining social engagement and management
of hypertension, diabetes, obesity, depression and hearing
loss. It is estimated that these interventions might delay or
prevent a third of all dementia cases [12]. Therefore, most
of the aforementioned interventions are also included in
the WHO Guidelines on risk reduction of cognitive de-
cline and dementia [13].
Currently, there is no cure for dementia, so prevention
of dementia is the key in fighting this disease. A diversity
of multi-domain lifestyle interventions was conducted in
elderly and people at risk for dementia in order to de-
crease the risk of developing dementia, including the
Finnish Geriatric Intervention Study to Prevent Cogni-
tive Impairment and Disability (FINGER) study, the
Multi-domain Alzheimer Preventive Trial (MAPT)
study, the Prevention of Dementia by Intensive Vascular
care (preDIVA) study and the Healthy Ageing Through
Internet Counselling in the Elderly (HATICE) trial [14–
17]. The aforementioned studies showed some evidence
for effectiveness of a multi-domain approach to prevent
elderly from cognitive decline, but further research is
needed [18–20]. Although health behavioural change is
crucial for dementia risk reduction, changing behaviour
is complex and many factors are related to the chances
for successfully altering behaviour according to different
social cognitive theories and models [21–25]. Measuring
beliefs and attitudes towards lifestyle adaptations for de-
mentia risk reduction may help to predict a person’s
willingness to change lifestyle and behaviour aiming to
reduce one’s risk of developing dementia.
The Motivation to Change Lifestyle and Health Behav-
iours for Dementia Risk Reduction (MCLHB-DRR) scale
was developed in Australia and measures the beliefs and
attitudes towards dementia and dementia risk reduction
[26]. The MCLHB-DRR scale was based on the Health
Belief Model (HBM), since the HBM was believed to be
the best-suited social cognitive model for dementia risk
reduction [26]. The HBM suggests that engagement in
health-promoting behaviour is defined by a person’s sub-
jective risk assessment of getting a condition and how
serious this condition and its consequences are, the per-
ceived benefits and barriers of performing this behav-
iour, a stimulus to trigger this behaviour, the desire to
achieve an outcome, and the confidence in one’s ability
to take action [27]. The MCLHB-DRR scale consists of
27 items and includes all seven subscales of the HBM:perceived susceptibility, perceived severity, perceived
benefits, perceived barriers, cues to action, general
health motivation and self-efficacy. The MCLHB-DRR
scale is considered to be valid and reliable in Australians
aged 50 years and older [26]. A Turkish version of the
MCLHB-DRR scale has been cross-culturally validated
and turned out to be a valid and reliable tool in individ-
uals aged 40 years and older [28]. To the best of our
knowledge, the MCLHB-DRR scale has not been cross-
culturally validated in any other languages or countries.
There is currently no instrument available to measure
attitudes and beliefs towards lifestyle and health behav-
ioural changes for dementia risk reduction in the
Netherlands. The MCLHB-DRR scale could be used to
measure the attitudes and beliefs towards lifestyle adap-
tations for dementia risk reduction in the Dutch popula-
tion. This induces the opportunity to use this scale in
developing tailored interventions or education programs
focused on lifestyle adjustments for dementia risk reduc-
tion. Therefore, the aim of the current study was to
translate and validate the MCLHB-DRR scale in the
Dutch general population aged between 30 and 80 years
old.
Methods
Study design and participants
MCLHB-DRR data were collected among a random sam-
ple of residents of the municipality of Groningen aged be-
tween 30 and 80 years old. Participants between 30 years
and 80 years old were included since health behaviour
change for dementia risk reduction is important during
midlife, but also in later life [12]. The prevalence of de-
mentia in the municipality of Groningen is estimated at
1100 cases in 2020 [29]. The percentage of residents with
dementia in the municipality of Groningen is generally
lower compared to other municipalities, probably due to a
lower average age of the residents [30]. Although healthy
ageing is an important mission of the municipality of Gro-
ningen, to the best of our knowledge, dementia friendly
initiatives or public health campaigns for dementia risk re-
duction do not exist yet. From the 101,518 residents of
the municipality of Groningen, 4500 residents stratified
for age (30–39, 40–49, 50–59, 60–69 and 70–80 years old)
and gender (male, female) were randomly selected by a
staff member of the municipality of Groningen, taken a re-
sponse rate of 12% into account. This staff member was
not involved in the data collection nor data analyses of
this study. The selected 4500 residents were invited by let-
ter to participate in an online survey about ‘Lifestyle and
dementia’. Potential participants had access to the online
survey using the web address which was mentioned in the
letter. The translated MCLHB-DRR scale was the last part
of this survey. The survey was built in Survey Monkey
(SurveyMonkey Inc., San Mateo, California, VS). In order
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were raffled among the participants. Furthermore, partici-
pants were offered to receive the survey results on popula-
tion level if they would finish the complete survey.
A pilot study was conducted to test the final version of
the online survey ‘Lifestyle and dementia’. A total of 25
people aged 30 to 80 years who were living outside the
municipality of Groningen participated in the pilot
study. They were recruited within the network of the re-
search team members. Results of the pilot study did not
lead to any changes in the final Dutch version of the
MCLHB-DRR scale.
Questionnaire
The MCLHB-DRR scale consists of 27 items covering
seven subscales: perceived susceptibility (4 items), per-
ceived severity (5 items), perceived benefits (4 items),
perceived barriers (4 items), cues to action (4 items),
general health motivation (4 items) and self-efficacy (2
items). Items are answered on a 5 point Likert-scale,
ranging from ‘strongly disagree’ (score = 1) to ‘strongly
agree’ (score = 5) [26].
Scale translation
For the translation of the MCLHB-DRR scale, we used
the method of Beaton et al. (2000) [31]. Briefly, the
MCLHB-DRR scale was translated into Dutch by three
native Dutch translators, independently. Two of these
translators were familiar with the concepts being exam-
ined in the questionnaire (the so-called informed trans-
lators). The third translator was not familiar with the
content or concepts of the questionnaire (uninformed
translator). All items, instructions and the response op-
tions of the questionnaire were translated.
Subsequently, the three translated versions were syn-
thesized to one Dutch version by the informed transla-
tors. The discrepancies between the three translated
versions were discussed between the informed transla-
tors, taking the original questionnaire into account.
Secondly, the synthesized Dutch version of the ques-
tionnaire was translated back into English by two inde-
pendent native English speakers (uninformed translators).
Both translators were not involved in the translation of
the questionnaire from English to Dutch and were blinded
to the original version of the questionnaire.
Afterwards all versions of the questionnaire, including
the original version, the three translated versions, the
synthesized Dutch version, the two back translations and
all written reports about the decisions being made dur-
ing the translation process were discussed by the in-
formed translators. Special attention was paid to achieve
semantic, idiomatic, experiential and conceptual equiva-
lence between the source and target version of the ques-
tionnaire. After a comprehensive review of all versionsof the questionnaire, consensus about the pre-final ver-
sion of the questionnaire was reached.
Finally, the two back translations were combined in
the best possible way and this version was send to the
developers of the original scale [26] to check whether
the meaning of the translated items was equivalent to
the meaning of the original items. Their feedback was
discussed, resulting in a small change in the translation
of item 20 and item 25. Afterwards, the Dutch final ver-
sion of the MCLHB-DRR scale was established.
Statistical analysis
First, study population characteristics and characteristics
of the MCLHB-DRR scale were calculated using descrip-
tive statistics. Second, exploratory factor analysis (EFA)
was performed. Maximum Likelihood estimation or
Principal Axis Factoring was used depending on whether
the data was roughly normally distributed or non-
normally distributed, respectively. Oblique rotation was
used as rotation method (delta (0)), which is taking into
account correlations among factors. If the correlations
between all factors were below 0.32, we changed to Vari-
max rotation [32]. Items that did not have a correlation
of 0.20 or higher with any of the other items were de-
leted immediately. Items with a high correlation (> 0.70)
with any of the other items, were considered carefully.
Items with a factor loading below 0.30 on any of the fac-
tors were deleted immediately. Deletion of an item was
considered if the item did not load sufficiently on one of
the factors (< 0.50) or if an item had a cross-loading
greater than 0.30 [33].
Internal consistency of the subscales was evaluated by
item-total correlations and Cronbach’s alpha. Deletion of
an item was considered when the item-total correlation
of an item was below 0.30 [33]. Cronbach’s alpha values
of 0.70 or higher were considered acceptable [34].
In addition, confirmatory factor analysis (CFA) was con-
ducted. The following fit indices and their required levels
were used to verify construct validity of the MCLHB-DRR
scale: Root Mean Squared Error of Approximation
(RMSEA) < 0.08 (moderate) and < 0.05 (excellent), Compara-
tive Fit Index (CFI) and Tucker-Lewis Index (TLI) > 0.90
(moderate) and > 0.95 (excellent) and χ2/df < 3.0 [35, 36].
EFA was performed using IBM SPSS Statistics software
version 23 (SPSS Inc., Chicago, IL, USA). CFA was ana-
lysed using Stata version 13 (StataCorp. 2013. Stata Statis-
tical Software: Release 13. College Station, TX: StataCorp
LP.). Participants who did not complete the whole
MCLHB-DRR scale were excluded from data analysis.
Ethics
This study was approved by the Medical Ethics Review
Board of the UMCG. All participants provided informed
consent.
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Participant recruitment
From the 4500 selected potential participants, 621 par-
ticipants completed the survey, which resulted in a re-
sponse rate of 14%. The data of the ‘cues to action’
subscale of three participants were missing. These par-
ticipants were excluded, leaving a total of 618 partici-
pants for data analysis.
Characteristics of the study population
The characteristics of the study population (n = 618) are
presented in Table 1. The mean age (standard deviation
(SD)) of the participants was 57.3 (13.5) years. More
than half of the participants were female (54%) and were
married or had a registered partnership (54%). Most par-
ticipants completed tertiary education (59%), followed by
upper secondary education (24%), lower secondary edu-
cation (14%) and elementary education (2%). About 58%
of the participants were employed. The percentage of
participants having a relative with dementia or a non-
relative with dementia was 45% and 21%, respectively.
The response rate within the different strata was lower
in the younger age categories (13% aged between 30 and
40, 12% aged between 40 and 50) compared to the older
age categories (20% aged between 50 and 60, 30% aged
between 60 and 70 and 22% aged between 70 and 80).
However, the distribution of males and females was
equally distributed within the age categories, except forTable 1 Study population characteristics
Characteristic All participants (N = 618)a
Age, years (mean ± SD) 57.3 ± 13.5
Gender (% male) 281 (46%)
Marital status
Married/registered partnership 336 (54%)
Domestic partnership 99 (16%)







Lower secondary 88 (14%)
Upper secondary 150 (24%)
Tertiary 363 (59%)
Others 6 (1%)
Working status (% currently working) 357 (58%)
Relative with dementia 276 (45%)
Non-relative with dementia 132 (21%)
aThe numbers of participants (percentages) are shown unless otherwise statedthe youngest age category aged 30 to 40 (female 67%;
male 33%).Analysis of the psychometric characteristics of the
MCLHB-DRR scale
Scale descriptives
The mean (SD) MCLHB-DRR subscale scores were 10.1
(2.7; range = 4 to 18) for perceived susceptibility, 13.9 (3.7;
range = 5 to 25) for perceived severity, 12.6 (2.9; range = 4
to 20) for perceived benefits, 8.0 (2.5; range = 4 to 15) for
perceived barriers, 10.2 (3.1; range = 4 to 19) for cues to
action, 14.5 (2.3; range = 4 to 20) for general health motiv-
ation and 5.8 (1.7; range = 2 to 10) for self-efficacy. All
subscale scores were approximately normally distributed.
Item response scores of the MCLHB-DRR scale ranged
from 1.9 (0.8; item 15) to 4.1 (0.7; item 24).Exploratory factor analysis
EFA analysis with extraction method Maximum Likeli-
hood and Oblimin rotation was used to assess the num-
ber of factors, because the data were roughly normally
distributed. First, a seven factor solution was evaluated,
as the original MCLHB-DRR scale consists of seven sub-
scales. All items had an inter-item correlation greater
than 0.20 with at least one of the other items. The cor-
relation between item 1 and item 2 was 0.86 (p < 0.001),
the correlation between item 1 and item 3 was 0.77 (p <
0.001) and the correlation between item 2 and item 3
was 0.82 (p < 0.001). Although these items had high
inter-item correlations, they still measured something
else (r < 0.90) and loaded on their intended factors.
Therefore, none of these items was deleted. All other
inter-item correlations did not exceed 0.70. The Bar-
tlett’s test of sphericity was significant, indicating that
the data was adequate for factor analysis (p < 0.001). The
first seven factors had eigenvalues greater than 1.00. The
eigenvalues and the cumulative percentages of explained
variance of the first seven factors in brackets were 5.86
(21.7%), 2.94 (32.6%), 2.52 (41.9%), 2.10 (49.7%), 1.56
(55.5%), 1.23 (60.0%) and 1.03 (63.9%), respectively. The
scree plot also suggested a seven factor model.
Almost all items loaded on their intended subscales
and did not have any significant cross-loadings. How-
ever, item 10 did not have a factor loading greater than
0.30 on any of the factors. Therefore, item 10 was de-
leted. Item 26 had a significant cross-loading (cross-
loading = 0.37) on the perceived benefits subscale. Fur-
thermore, items 4, 5, 7, 9, 13, 25 and 26 had factor load-
ings between 0.30 and 0.50 on their intended factors
(Table 2). Inclusion of these items was assessed in the
next step by evaluating the internal consistency of their
subscale. The inter-scale correlations between the sub-
scale factors ranged from − 0.13 to 0.51.
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Item-total correlation analysis showed that all items were
positively correlated with the total MCLHB-DRR scale
score. Item-total correlations ranged from 0.15 to 0.67.
The item-total correlations of item 14 (r = 0.28), item 22
(r = 0.15), item 23 (r = 0.26) and item 24 (rs = 0.19) were
lower than 0.30. All other items had an item-total correl-
ation above 0.30. Cronbach’s alpha values were α = 0.86
for perceived susceptibility, α = 0.76 for perceived severity,Table 2 Exploratory factor analysis of the MCLHB-DRR scale (N = 61
Q1 My chances of developing dementia are great
Q2 I feel that my chances of developing dementia in the future are high
Q3 There is a strong possibility that I will develop dementia
Q4 Within the next 10 years I will develop dementia
Q5 The thought of dementia scares me
Q6 When I think about dementia my heart beats faster
Q7 My feelings about myself would change if I develop dementia
Q8 When I think about dementia I feel nauseous
Q9 It would be more serious for me to develop dementia than if I develop
other diseases
Q10 Information and advice from experts may give me something that I ne
thought of, and may reduce my chance of developing dementia
Q11 Changing my lifestyle and health habits can help me reduce my chanc
of developing dementia
Q12 I have a lot to gain by changing my lifestyle and health behaviour
Q13 Adapting to a healthier lifestyle and behaviour would prevent dement
for me
Q14 I am too busy to change my lifestyle and health habits
Q15 My financial situation does not allow me to change my lifestyle and
behaviour
Q16 Family responsibilities make it hard for me to change my lifestyle and
behaviour
Q17 Changing lifestyle and behaviour interferes with my schedule
Q18 Being forgetful makes me think I have to change my lifestyle and
behaviour
Q19 Having risk factor(s) for dementia makes me think I have to change my
lifestyle and behaviour
Q20 Learning more about dementia from the media makes me think I have
to change my lifestyle and behaviour
Q21 Knowing family member(s) with dementia makes me think I have to
change my lifestyle and behaviour
Q22 Nothing is as important to me as good health
Q23 I often think about my health
Q24 I think I have to pay attention to my own health
Q25 I am concerned about my health
Q26 I am certain that I can change my lifestyle and behaviour so I can redu
the risk of developing dementia
Q27 I am able to make differences that will change the risk of developing
dementia
The factor loadings greater than 0.30 are shown in boldα = 0.76 for perceived benefits, α = 0.77 for perceived bar-
riers, α = 0.84 for cues to action, α = 0.64 for general
health motivation and α = 0.81 for self-efficacy, all indicat-
ing good internal consistency. Cronbach’s alpha of the
perceived susceptibility, perceived benefits and general
health motivation subscales could be elevated by deleting
an item. Items 4, 13 and 25 already had low factor load-
ings (factor loadings < 0.50) and were therefore eliminated.
After deletion of these items, Cronbach’s alpha values8, Maximum Likelihood with Oblimin rotation)
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7
-0.02 0.90 0.00 -0.03 -0.03 0.03 0.04
0.00 0.97 0.02 -0.04 -0.03 0.00 -0.00
0.04 0.86 -0.03 0.01 0.02 -0.03 0.04
-0.04 0.33 0.07 0.25 0.07 -0.04 -0.12
0.01 0.08 0.02 0.49 0.05 0.09 0.10
-0.06 -0.00 0.10 0.81 0.01 -0.02 -0.04
0.04 -0.01 -0.12 0.43 -0.01 0.03 0.10
-0.03 -0.03 0.03 0.80 0.06 -0.05 -0.12
ed 0.03 0.05 0.06 0.45 -0.04 0.00 -0.03
ver 0.15 0.01 0.18 0.17 -0.09 0.01 0.20
e 0.07 0.06 0.06 0.01 -0.04 -0.05 0.77
-0.03 0.03 0.08 0.01 0.05 -0.01 0.77
ia 0.13 -0.06 0.10 0.06 0.10 0.01 0.38
0.02 -0.03 0.00 -0.02 0.61 -0.05 -0.01
0.02 -0.02 0.06 0.05 0.62 0.05 -0.07
-0.01 0.04 -0.09 -0.02 0.78 0.03 0.05
-0.02 -0.02 0.07 -0.00 0.68 -0.06 0.06
0.02 0.01 0.68 -0.02 0.05 0.01 -0.03
0.01 0.03 0.81 -0.03 -0.01 0.01 0.04
-0.01 -0.03 0.71 0.02 -0.03 0.03 0.17
0.07 0.04 0.64 0.03 0.08 -0.02 0.00
-0.03 -0.11 0.05 0.10 -0.08 0.51 -0.10
0.00 -0.01 -0.03 -0.02 0.03 0.85 0.01
0.07 0.05 -0.05 -0.09 -0.01 0.63 -0.00
-0.07 0.09 0.17 0.12 0.06 0.32 0.12
ce 0.47 0.03 0.16 -0.05 -0.03 0.03 0.37
1.02 -0.00 0.02 0.03 0.04 0.02 -0.07
Table 3 Internal consistency of the subscales




No. of items Range of scores Mean ± SD α No. of items Range of scores Mean ± SD α
Perceived susceptibility 4 4–18 10.1 ± 2.7 0.86b 4 4–19 NK 0.86
Perceived severity 5 5–25 13.9 ± 3.7 0.76 5 5–25 NK 0.73
Perceived benefits 3a 3–15 9.1 ± 2.3 0.76c 4 4–20 NK 0.69
Perceived barriers 4 4–15 8.0 ± 2.5 0.77 4 4–20 NK 0.74
Cues to action 4 4–19 10.2 ± 3.1 0.84 4 4–20 NK 0.68
General health motivation 4 4–20 14.5 ± 2.3 0.64d 4 4–20 NK 0.61
Self-efficacy 2 2–10 5.8 ± 1.7 0.81 2 2–10 NK 0.66
aItem 10 is deleted
bCronbach’s alpha elevated to 0.93 if item 4 was deleted
cCronbach’s alpha elevated to 0.80 if item 13 was deleted
dCronbach’s alpha elevated to 0.69 if item 25 was deleted
Abbreviations: α Cronbach’s alpha, MCLHB-DRR Motivation to Change Lifestyle and Health Behaviours for Dementia Risk Reduction, NK Not known
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ceived benefits and α = 0.69 for general health motivation.
Cronbach’s alpha of all subscales could not be raised any
further after deleting these items (Table 3).
Confirmatory factor analysis
CFA with Maximum Likelihood method was conducted
to explore the model fit of the MCLHB-DRR scale. A
seven factor model including all 27 items (model 1) was
evaluated with CFA. The fit indices were indicating a
moderate fit (RMSEA = 0.053, CFI = 0.920, TLI = 0.907,
χ2/df = 2.743). A seven factor model with 23 items (ex-
cluding items 4, 10, 13 and 25) (model 2) showed an ex-
cellent fit (RMSEA = 0.043, CFI = 0.960, TLI = 0.951, χ2/
df = 2.130), indicating model 2 had a better fit to the
data than model 1 (Table 4). The factor loadings of
model 2 ranged from 0.395 to 0.978 and were all statisti-
cally significant (Table 5).
Discussion
We demonstrated that the Dutch version of the
MCLHB-DRR scale, consisting of 23 items, is a valid in-
strument to measure the beliefs and attitudes towards
lifestyle and health behavioural changes for dementia
risk reduction in people aged between 30 and 80 years
old. EFA showed that nearly all items loaded on their
intended factors without cross-loadings. Cronbach’sTable 4 Goodness of fit indexes of MCLHB-DRR models





Model 1 represents a seven factor model including all 27 items; model 2 represents
Abbreviations: RMSEA Root Mean Squared Error of Approximation, CFI Comparative
and Health Behaviours for Dementia Risk Reduction, NK Not knownalpha varied from 0.69 to 0.93, indicating good internal
consistency. CFA confirmed that a seven factor model
including 23 items (without items 4, 10, 13 and 25) had
an excellent fit to the data (RMSEA = 0.043, CFI = 0.960,
TLI = 0.951, χ2/df = 2.130).
Items 4, 10, 13 and 25 had low factor loadings and
were therefore not included in the final Dutch version of
the instrument. This could possibly be explained by dif-
ferences in knowledge of dementia and dementia pre-
vention between residents of Australia and the
Netherlands. Australia is leading in the field of dementia
prevention with the world first publicly-funded dementia
prevention program [37]. This could have increased the
public awareness about dementia and the prevention of
dementia in Australia. In general, the Australian popula-
tion scored higher on all subscales of the MCLHB-DRR
scale, except for the self-efficacy subscale where the
Dutch sample had a higher score [26]. Differences in
cultural beliefs about general health, health behaviours
and the prestige of health professionals may play a role.
Another explanation is the age difference between the
Australian and Dutch study populations [26]. The study
population of the Australian study was 50 years and
older whereas our population was between 30 and 80
years (73% was 50 years or older). People aged below 50
years might be less scared to develop dementia in the





a seven factor model including 23 items (without items 4, 10, 13 and 25)
Fit Index, TLI Tucker-Lewis Index, MCLHB-DRR Motivation to Change Lifestyle
Table 5 Confirmatory Factor Analysis report
Subscales Item Factor Loading
Perceived severity Q1 0.896*
Q2 0.953*
Q3 0.858*





Perceived benefits Q11 0.842*
Q12 0.797*













Results are shown for model 2. *p < 0.001
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over. However, our sensitivity analysis in which we only
included people aged 50 years and over did not change
our results in any way. Deficiencies in the translation
process could be a third explanation. The translation of
item 10 slightly changed, as the part of the sentence
‘may give me something that I never thought of’ is not
included in the Dutch translation.
Strengths and limitations
To our knowledge, this was the first study that validated
the MCLHB-DRR scale in the Dutch general population.
A major strength of the current study was the random
sample, as the information letter was send to randomly
selected residents of the municipality of Groningen. An-
other strength is the adequate sample size, consisting of
a total number of 618 participants. Besides, we followed
formal guidelines presented by Beaton et al. (2000) dur-
ing the translation process [31].
This study also had certain limitations. The response
rate of the current study was 14%, which is relatively
low. However, we used several methods which have
shown to increase the response rate to electronicsurveys, such as a lottery to win a voucher, an offer to
receive survey results on population level, a personalised
invitation letter, an easily accessible link to the survey
and a deadline to complete the survey [38, 39]. In our
study, 59% of the participants completed tertiary educa-
tion, which is higher than the percentage completing ter-
tiary education in Dutch residents aged 45 years and
over (26%) [40]. Therefore, the sample is not fully repre-
sentative for the Dutch general population.
Recommendations for future research
First, assessing the reliability and responsiveness of the
Dutch MCLHB-DRR scale would be a valuable addition
for future research. Second, a part of the study popula-
tion might not be familiar with the health behaviours
that decrease the risk of developing dementia. Future re-
search could consider informing participants about these
health behaviours before filling in the MCLHB-DRR
scale. Further research should also examine the associ-
ation between the motivation to change lifestyle and
health behaviours for dementia risk reduction and actu-
ally conducting this behaviour in daily life.
Implications
This scale can be useful in developing and evaluating in-
terventions aimed at dementia risk reduction in various
ways. Firstly, this instrument might help to predict
people who will comply with an intervention program
aimed at dementia prevention. Secondly, this instrument
can be used in developing tailored interventions based
on a person’s motivations and beliefs. For example, if an
individual scores low on the perceived benefits subscale,
it would be convenient to educate this individual about
how changing lifestyle and health behaviours could re-
duce its risk of dementia. Finally, assessing the beliefs to-
wards lifestyle and health behavioural changes in the
community population of the Netherlands may help to
develop media campaigns or education programs fo-
cused on dementia prevention.
Conclusion
In summary, we have demonstrated that the translated
and adapted Dutch version of the MCLHB-DRR scale,
consisting of 23 items, is a valid instrument to assess
health beliefs and attitudes towards dementia and de-
mentia risk reduction in the Dutch general population
aged between 30 and 80 years old. The MCLHB-DRR
scale can be used in the development and evaluation of
lifestyle interventions and media campaigns aimed at de-
mentia risk reduction.
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